Bridging the Gap: Strategic Preclinical Manufacturing for Viral Vector Success
The landscape of gene therapy is shifting. As the industry moves from speculative R&D toward a robust clinical pipeline, the...
The landscape of gene therapy is shifting. As the industry moves from speculative R&D toward a robust clinical pipeline, the...